Polyclonal Rabbit anti‑Human FLNB / TAP Antibody (FITC, aa1175‑1457, WB) LS‑C695440
Polyclonal Rabbit anti‑Human FLNB / TAP Antibody (FITC, aa1175‑1457, WB) LS‑C695440
Antibody:
FLNB / TAP Rabbit anti-Human Polyclonal (aa1175-1457) (FITC) Antibody
Overview
Antibody:
FLNB / TAP Rabbit anti-Human Polyclonal (aa1175-1457) (FITC) Antibody
Specifications
Description
TAP antibody LS-C695440 is an FITC-conjugated rabbit polyclonal antibody to human TAP (FLNB) (aa1175-1457). Validated for WB.
Target
Human FLNB / TAP
Synonyms
FLNB | ABP-280 | ABP-280 homolog | AOI | ABP-278 | Actin binding protein 278 | Actin-binding-like protein | Filamin homolog 1 | FLN1L | FLN3 | FH1 | Filamin-3 | LRS1 | TAP | Thyroid autoantigen | Beta-filamin | Filamin B, beta | Filamin-B | FLN-B | TABP | Truncated ABP
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
FITC.
Also available
Unconjugated or conjugated with
Biotin,
Cy3,
HRP,
APC,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant FLNb (Gly1175-Val1457)
Specificity
The antibody is a rabbit polyclonal antibody raised against FLNb.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
ICC, Immunofluorescence, Western blot
Reactivity:
Human
Range:
0.313-20 ng/ml
Reactivity:
Mouse
Range:
1.56-100 ng/ml
Reactivity:
Human
Range:
31.25-2000 pg/ml
Reactivity:
Human
Range:
31.25-2000 pg/ml
Reactivity:
Rat
Range:
93.75-6000 pg/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 8/31/2024